Satellos Bioscience Stock Analysis
| MSCL Stock | 0.84 0.01 1.20% |
As of the 11th of January 2026, Net Debt To EBITDA is likely to grow to 0.30, though Net Debt is likely to grow to (49.3 M). With a high degree of financial leverage come high-interest payments, which usually reduce Satellos Bioscience's Earnings Per Share (EPS).
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.87 | Current Value 0.78 | Quarterly Volatility 0.05008996 |
Satellos Bioscience is overvalued with Real Value of 0.67 and Hype Value of 0.84. The main objective of Satellos Bioscience stock analysis is to determine its intrinsic value, which is an estimate of what Satellos Bioscience is worth, separate from its market price. There are two main types of Satellos Bioscience's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Satellos Bioscience's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Satellos Bioscience's stock to identify patterns and trends that may indicate its future price movements.
The Satellos Bioscience stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Satellos Bioscience is usually not traded on Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day. Satellos Stock trading window is adjusted to America/Toronto timezone.
Satellos |
Satellos Stock Analysis Notes
The book value of the company was now reported as 0.26. The company had not issued any dividends in recent years. Satellos Bioscience had 1:20 split on the 18th of August 2021. To find out more about Satellos Bioscience contact Francis MBA at 647-660-1780 or learn more at https://satellos.com.Satellos Bioscience Investment Alerts
| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience had very high historical volatility over the last 90 days | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Satellos Bioscience Set For Growth As Momentum Builds Fast - Kalkine Media |
Satellos Largest EPS Surprises
Earnings surprises can significantly impact Satellos Bioscience's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-08-13 | 2025-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2025-05-13 | 2025-03-31 | -0.05 | -0.06 | -0.01 | 20 | ||
2025-03-26 | 2024-12-31 | -0.05 | -0.06 | -0.01 | 20 |
Satellos Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 154.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Satellos Bioscience's market, we take the total number of its shares issued and multiply it by Satellos Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Satellos Profitablity
Satellos Bioscience's profitability indicators refer to fundamental financial ratios that showcase Satellos Bioscience's ability to generate income relative to its revenue or operating costs. If, let's say, Satellos Bioscience is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Satellos Bioscience's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Satellos Bioscience's profitability requires more research than a typical breakdown of Satellos Bioscience's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (5.70) | (5.99) | |
| Return On Capital Employed | (2.25) | (2.36) | |
| Return On Assets | (2.10) | (2.21) | |
| Return On Equity | (3.87) | (3.67) |
Management Efficiency
Satellos Bioscience has return on total asset (ROA) of (0.5425) % which means that it has lost $0.5425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8759) %, meaning that it generated substantial loss on money invested by shareholders. Satellos Bioscience's management efficiency ratios could be used to measure how well Satellos Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of January 2026, Return On Tangible Assets is likely to drop to -5.99. In addition to that, Return On Capital Employed is likely to drop to -2.36. At this time, Satellos Bioscience's Total Assets are very stable compared to the past year. As of the 11th of January 2026, Other Current Assets is likely to grow to about 3.1 M, while Non Current Assets Total are likely to drop 5,461.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.09 | 0.11 | |
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (0.66) | (0.69) | |
| Price Book Value Ratio | 2.68 | 2.81 | |
| Enterprise Value Multiple | (0.66) | (0.69) | |
| Price Fair Value | 2.68 | 2.81 | |
| Enterprise Value | 6.8 M | 6.5 M |
Leadership effectiveness at Satellos Bioscience is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 11th of January 2026, Satellos Bioscience has the Semi Deviation of 3.57, coefficient of variation of 2608.67, and Risk Adjusted Performance of 0.0369. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Satellos Bioscience, as well as the relationship between them.Satellos Bioscience Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Weighted Moving Average calculates a weight for each value in Satellos Bioscience price series with the more recent values given greater weights.
Satellos Bioscience Outstanding Bonds
Satellos Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Satellos Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Satellos bonds can be classified according to their maturity, which is the date when Satellos Bioscience has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Satellos Bioscience Predictive Daily Indicators
Satellos Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Satellos Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Satellos Bioscience Forecast Models
Satellos Bioscience's time-series forecasting models are one of many Satellos Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Satellos Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Satellos Bioscience Debt to Cash Allocation
Satellos Bioscience has accumulated 5.16 M in total debt. Debt can assist Satellos Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Satellos Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Satellos Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Satellos to invest in growth at high rates of return. When we think about Satellos Bioscience's use of debt, we should always consider it together with cash and equity.Satellos Bioscience Total Assets Over Time
Satellos Bioscience Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Satellos Bioscience uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Satellos Bioscience Debt Ratio | 78.0 |
Satellos Bioscience Corporate Bonds Issued
Satellos Net Debt
About Satellos Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Satellos Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Satellos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Satellos Bioscience. By using and applying Satellos Stock analysis, traders can create a robust methodology for identifying Satellos entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Satellos Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.